• Target：
• PI3 Kinase p85 β

• Fields：
• >>EGFR tyrosine kinase inhibitor resistance;>>Endocrine resistance;>>Platinum drug resistance;>>ErbB signaling pathway;>>Ras signaling pathway;>>Rap1 signaling pathway;>>cAMP signaling pathway;>>Chemokine signaling pathway;>>HIF-1 signaling pathway;>>FoxO signaling pathway;>>Phosphatidylinositol signaling system;>>Sphingolipid signaling pathway;>>Phospholipase D signaling pathway;>>Autophagy - animal;>>mTOR signaling pathway;>>PI3K-Akt signaling pathway;>>AMPK signaling pathway;>>Apoptosis;>>Longevity regulating pathway;>>Longevity regulating pathway - multiple species;>>Cellular senescence;>>Axon guidance;>>VEGF signaling pathway;>>Osteoclast differentiation;>>Focal adhesion;>>Signaling pathways regulating pluripotency of stem cells;>>Platelet activation;>>Neutrophil extracellular trap formation;>>Toll-like receptor signaling pathway;>>C-type lectin receptor signaling pathway;>>JAK-STAT signaling pathway;>>Natural killer cell mediated cytotoxicity;>>T cell receptor signaling pathway;>

• Gene Name：
• PIK3R2

• Protein Name：
• Phosphatidylinositol 3-kinase regulatory subunit beta

• Human Gene Id：
• 5296

• Human Swiss Prot No：
• O00459

• Mouse Gene Id：
• 18709

• Mouse Swiss Prot No：
• O08908

• Rat Swiss Prot No：
• Q63788

• Immunogen：
• Synthesized phospho-peptide around the phosphorylation site of human PI 3-kinase p85β (phospho Tyr464)

• Specificity：
• Phospho-PI 3-kinase p85β (Y464) Polyclonal Antibody detects endogenous levels of PI 3-kinase p85β protein only when phosphorylated at Y464.

• Formulation：
• Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.

• Source：
• Polyclonal, Rabbit,IgG

• Dilution：
• WB 1:500 - 1:2000. ELISA: 1:10000. Not yet tested in other applications.

• Purification：
• The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.

• Concentration：
• 1 mg/ml

• Storage Stability：
• -15°C to -25°C/1 year(Do not lower than -25°C)

• Other Name：
• p85;p85 beta;p85-BETA;P85B;P85B_HUMAN;Phosphatidylinositol 3 kinase;Phosphatidylinositol 3 kinase regulatory beta subunit;Phosphatidylinositol 3 kinase regulatory subunit beta;Phosphatidylinositol 3 kinase regulatory subunit polypeptide 2;Phosphatidylinositol 3 kinase, regulatory subunit, polypeptide 2 (p85 beta);Phosphatidylinositol 3-kinase 85 kDa regulatory subunit beta;phosphatidylinositol 3-kinase;Phosphatidylinositol 3-kinase regulatory beta subunit;Phosphatidylinositol 3-kinase regulatory subunit beta;Phosphoinositide 3 kinase regulatory subunit 2 (beta);Phosphoinositide 3 kinase regulatory subunit 2;Phosphoinositide 3 kinase regulatory subunit polypeptide 2 (p85 beta);Phosphoinositide 3 kinase regulatory subunit polypeptide 2;Phosphoinositide 3 kinase, regulatory subunit 2 (beta);Phosphoinositide 3 kinase, regulatory subunit 2 (p85 beta);PI3 kinase p85 beta subunit;PI3 kinase p85 subunit beta;PI3-kinase regulatory subunit beta;PI3-kinase subunit p85-beta;PI3K;PI3K regulatory su

• Observed Band(KD)：
• 85kD

• Background：
• Phosphatidylinositol 3-kinase (PI3K) is a lipid kinase that phosphorylates phosphatidylinositol and similar compounds, creating second messengers important in growth signaling pathways. PI3K functions as a heterodimer of a regulatory and a catalytic subunit. The protein encoded by this gene is a regulatory component of PI3K. Two transcript variants, one protein coding and the other non-protein coding, have been found for this gene. [provided by RefSeq, Dec 2012],

• Function：
• function:Binds to activated (phosphorylated) protein-tyrosine kinases, through its SH2 domain, and acts as an adapter, mediating the association of the p110 catalytic unit to the plasma membrane.,similarity:Belongs to the PI3K p85 subunit family.,similarity:Contains 1 Rho-GAP domain.,similarity:Contains 1 SH3 domain.,similarity:Contains 2 SH2 domains.,subunit:Heterodimer of a p110 (catalytic) and a p85 (regulatory) subunits.,

• Subcellular Location：
• nucleus,cytosol,phosphatidylinositol 3-kinase complex,

• Expression：
• Brain,Epithelium,Kidney,Placenta,

• June 19-2018
• WESTERN IMMUNOBLOTTING PROTOCOL

• June 19-2018
• IMMUNOHISTOCHEMISTRY-PARAFFIN PROTOCOL

• June 19-2018
• IMMUNOFLUORESCENCE PROTOCOL

• September 08-2020
• FLOW-CYTOMEYRT-PROTOCOL

• May 20-2022
• Cell-Based ELISA│解您多样本WB检测之困扰

• July 13-2018
• CELL-BASED-ELISA-PROTOCOL-FOR-ACETYL-PROTEIN

• July 13-2018
• CELL-BASED-ELISA-PROTOCOL-FOR-PHOSPHO-PROTEIN

• July 13-2018
• CELL-BASED-COLORIMETRIC-ELISA-PROTOCOL-FOR-TOTAL-PROTEIN

• July 13-2018
• Antibody-FAQs